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ABSTRACT
Genetic studies often involve huge number of covariants that interact with each other, in
the form of expressions or mutations. It is crucial to mine important covariants associated
with different diseases for better clinical treatment. Traditional statistical methods have
been successful in testing single covariants, but are limited when studying the joint effect
of multiple related genes. Hence, incorporating biological interaction networks becomes
a promising approach for genetic association study. On the other hand, the advance of
graph learning algorithms has made it possible to build data-driven models for large graph
problems. These methods generally fall into two categories: 1) random walk and 2) deep
graph neural net. We study how to leverage information from biological networks under
these frameworks to solve genetic association problems on large scale. Towards this end,
we have applied graph neural network to cancer prognostic prediction. We also develop a
network diffusion method for variant association study for Parkinson’s disease. Our results
demonstrate the power of graph learning algorithms in biological domain.
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CHAPTER 1: OVERVIEW
1.1 MACHINE LEARNING IN COMPUTATIONAL BIOLOGY
Computational biology is the science of using biological data to develop algorithms or
models in order to understand biological systems and relationships. While biologists conduct
in vivo and in vitro experiments for scientific discoveries, they are facing a large search space
of bio-molecule structures, gene sequences, mutations, and many others. On the other hand,
these experiments can be prohibitively expensive such that exhaustive search in wet lab is
unaffordable. To alleviate this issue, computational biologists design algorithms and models
to analyze biological data obtained from wet lab. Their in silico work not only reveals the
underlying biological relationships from data, but also guides in vivo and in vitro experiments
by proposing high-quality hypotheses, reducing the search space by a significant amount.
In the past, computational biologists have largely focused on designing combinatorial
and statistical methods that work on a relatively small amount of data. With the recent
development of Next-Generation Sequencing (NGS), massive amount of data is now available
for study. It is crucial to design new methods that are both computationally and statistically
efficient for analyzing data on a large scale. Machine learning, which has achieved huge
success in domains such as vision, natural language processing and social network mining,
has become increasingly popular in bioinformatics.
However, new challenges arise for using machine learning techniques in computational
biology. First, biological data are typically in a large feature space, which can be genes,
proteins or molecule structures, with a relatively small amount of samples. A large portion
of machine learning algorithms, including deep learning, are data hungry, meaning that they
may fail when the number of features far exceeds the number of data points. It is occasionally
possible to do feature selection by expert knowledge, but in most cases people have no idea
which part of the features are important for the problem. Essentially, we need to design
algorithms that can automatically handle a large feature space and find useful features.
Secondly, biological data have different structures in the form of matrices, sequences and
graphs. Even in a single task there may be different data structures involved. For example,
a protein interaction network may be constructed from the matrix data of patient muta-
tion profiles. How to incorporate the heterogeneous data structures in machine learning
algorithms becomes another critical issue in algorithm design.
In summary, machine learning has become increasingly popular in computational biology.
Nevertheless, to leverage its power, we need to carefully design algorithms and models that
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overcome the aforementioned challenges. In this thesis, we will focus on handling one specific
type of data, namely the biological interaction network.
1.2 BIOLOGICAL INTERACTION NETWORKS
Biological networks are summarized information networks constructed from multiple sources
of data. The data source could be from experiments, literature or databases. Protein in-
teraction networks and gene interaction networks are two common examples, and they can
translate to each other in the way that genes encode proteins. In a protein interaction net-
work, each node corresponds to a unique protein. Each edge denotes interaction between two
proteins. Sometimes a weight is assigned to the edge, indicating the strength of interaction
or correlation.
Biological interaction networks serve as databases in graph structure, encoding human
knowledge about genes and proteins. So far they have been used for case study and feature
selection. However, we hope to design a systematic way to incorporate the network as part
of the machine learning algorithm to solve problems that involve modeling protein/gene
interactions. To this end, we turn to machine learning on graphs, a subfield of machine
learning that specifically deals with graph-type data.
1.3 MACHINE LEARNING ON GRAPHS
Graphs are ubiquitous structures in computer science. Typical examples include social
networks, academic citation graphs, knowledge graphs, and biochemical molecule structures.
Graphs model the interaction between vertices. In contrast to learning over the classical
matrix data, where each data point is assumed to be independent, learning over graph is
able to capture the relationship among each pair of nodes, as well as the holistic graph
topology.
Learning methods over graphs mainly fall into two categories: 1) random walk-based
methods, which is more traditional and has been widely used, 2) deep graph neural network,
which appears recently and achieves great performance on large scale problems. Random
walk models the diffusion of a probability matrix through the graph. Information is prop-
agated towards neighboring nodes to reflect the graph structure. One famous example is
Google’s PageRank, which propagates node importance to rank all websites.
Deep graph neural networks takes the philosophy of both random walk and graph convo-
lution. Each node is represented by a low dimensional vector. Every time the node vector
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is updated by neighborhood aggregation, which propagates the information from its neigh-
boring node vectors. Optionally, the node vectors can be further aggregated to obtain a
graph-level representation for classifiying the whole graph.
In our study, we use random walk and graph neural network for two different problems
respectively. We first apply graph neural network to cancer prognostic prognosis, where we
use gene expressions over the interaction network to predict patient survival. We also devise
a random walk-based method for neural degenerative disease stratification. We will describe
these two studies in Chapter 2 and 3.
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CHAPTER 2: CANCER PROGNOSIS PREDICTION
2.1 INTRODUCTION
We study the biological problem of cancer prognosis prediction, which falls into the larger
category of survival analysis. Given certain features of a cancer patient, such as information
about gene expression and somatic mutation, the task is to predict the patient’s survival time.
Several machine learning frameworks have been developed for prognosis prediction, including
Cox-proportional hazards regression (Cox-PH)[1], Cox-boost[2], Cox-nnet[3], and random
survival forest[4]. However, none of these models is able to incorporate prior biological
knowledge that would be helpful to prognosis prediction. In particular, the protein-protein
interaction networks (PPI networks) carry rich relational information about genes. It is
promising to make improvement on prognosis prediction by incorporating PPI networks into
the classical learning frameworks for survival analysis.
We start by reviewing both the classical statistical model for prognostic prediction, and the
recently developed graph learning techniques that are potentially applicable to our problem.
Then we will describe our adapted method, followed by experiment results and analysis. In
section 2.2 we will establish a general Cox-PH framework for survival analysis and introduce
existing methods on the framework. In section 2.3 we review graph learning techniques and
discuss about applicability of these methods to our problem. We conducted experiments on
a real world cancer dataset with two different types of graph neural networks, of which the
details are described in section 2.4 and 2.5. To adjust the existing graph neural network
architecture to our problem, we design two novel loss functions based on the classical partial
log likelihood, which increase memory efficiency and allow training over arbitrarily large
population scale. Experiment results are presented and analyzed in section 2.6. We compare
our methods against baselines and discuss why they succeed or fail.
2.2 SURVIVAL ANALYSIS IN CANCER GENOMICS
In this section we introduce the Cox-PH model and its extensions [1].
2.2.1 Cox proportional hazards regression
Let T be the random variable indicating the survival time of the patient. The hazard
function h(t) is the (probability) density of death at time t conditioned on survival until
4
time t or later. Formally,
h(t) = lim
∆t→0
Pr(t ≤ T < t+ ∆t)
∆t · Pr(T > t)
(2.1)
One can think of the hazard function as measuring the likelihood of death right after time
t given the patient is still alive at time t.
Since we care about the survival of multiple patients, h(t) should be different across
patients. Let xi be the feature vector of patient i, in general h(t|xi) is a function of both t
and xi, i.e. h(t|xi) = f(t, xi).
The Cox proportional hazards regression models h(t|xi) as




Here, h0(t) is the baseline hazard at time t, corresponding to the hazard when xi = 0. β is
the parameter estimating the importance of each feature in xi. Notice that β is independent
of time. Hence the cox model separates the dependence on t and xi apart from each other.
Specifically, the hazard ratio defined as h(t|xi)/h0(t) is time invariant.
Typically the data for survival contains both the feature vector xi and the survival time
ti for each patient. A patient record is censored if death does not occur during the time of
observation. In this case, we do not know the survival time of the patient. We only know it
is longer than the observation duration. Let C(i) be the indicator of a record being censored
or not. C(i) = 1 if record i is uncensored, and C(i) = 0 if censored.














which is independent of h0(t).
The objective function used in Cox-PH is the partial log-likelihood over all observed events,











It is called ”partial” because each li is conditioned on observing exactly one death at time
ti. Following the maximum likelihood estimation, we can maximize the partial log-likelihood
5
to estimate the parameter β.
As a final remark, the objective PL(β) is essentially a multi-class cross entropy loss with
softmax over the logits θ’s. On the other hand, θ is a linear function of the input x. Hence,
Cox-PH is essentially a logistic regression model. Cox-boost modifies Cox-PH by applying
”gradient boosting” in training [2]. This is a standard way of using boosting to improve
logistic regression model, which we do not discuss in detail.
2.2.2 Cox-nnet
In Cox-PH, the logits θi is linear in the input xi, which implies that different features
contribute to the hazard ratio independently. This naive assumption is not desirable as
co-occurrence of two specific features may result in a much larger impact on survival, for
example, expression of two functionally related genes. Cox-PH can be too simple to model
complicated patterns on gene level. Cox-nnet replaces the linear predictor with a multi-layer
perceptron (MLP) of 1 hidden layer. [3] Specifically, they compute θi as
θi = G(Wxi + b)
>β (2.6)
Here W is the transforming matrix from input to hidden layer, b is the bias on hidden
layer, and G is the non-linear activation function applied coordinate-wise. In their paper,
the tanh function is used for G. Similarly, Cox-nnet maximize the partial log-likelihood to
estimate parameters W , b, β.
Although Cox-nnet is advantageous in model capacity compared with Cox-PH, overfitting
becomes a big problem as the artificial neural network, or MLP, introduces too many pa-
rameters. Let m be the input dimension (the number of input features), n be the number
of patients in the dataset. Usually, n ≈ 103 ∼ 104. Following the authors’ design, they
set the hidden layer size to be the square root of the input size. Thus the total number of
parameters in Cox-nnet is O(m3/2). Typically m ≈ 104, which results in millions of param-
eters. Hence, we expect that modifying the network structure by reducing the number of
parameters would substantially improve the performance.
Besides that, the Cox-nnet is incapable of incorporating prior biological knowledge on
genes. Since the size of survival dataset is usually small, incorporating knowledge from
outside resources can potentially benefit the performance as a type of data augmentation.
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2.3 GRAPH NEURAL NETWORKS
In this section, we review several graph neural networks that are potentially useful to
prognosis prediction. Before that, we first look at how to reformulate the Cox model to
include a graph neural network.
2.3.1 General framework
We consider the protein-protein interaction (PPI) network as our outside knowledge. The
PPI network represents the relationship between proteins, and equivalently between genes.
To incorporate this graph structure into the prediction model, we can modify the network
structure that outputs θi. In general, we define an attributed graph (G,X), whereG = (V,E)
is the unweighted PPI network whose nodes are genes, and the k−th row of matrix, denoted
by xk, is the feature vector on gene k. Suppose we have information on N genes and there are
D features for each gene, then X ∈ RN×D. We compute θ through a graph neural network
(GNN).
θ = (GNN(G,X))>β (2.7)
Notice that G is fixed across patients since we use the same PPI network for all patients.
This is typically represented as an adjacency matrix A ∈ RN×N . The output θ only depends
the input feature X which is distinct for each patient. Compared with the vectorized input
used in Cox-PH and Cox-nnet, here we reorganize the same input into a matrix.
In the rest of this section, we will explore the possibility of the ”GNN” by reviewing the
recently developed graph neural networks. The general idea of graph neural network is to
treat the input graph as a computation graph. At each time step, the node state is updated
by aggregating information from its neighbors. Figure 2.1 shows the information flow in
neighborhood aggregation. 1
We simplify the message passing framework suggested in [6] to divide a graph neural
network into two phases: a message passing phase and a readout phase. The message
passing phase runs for T steps. At each step t, the hidden state htv of each node v is updated
by the message from neighbors:
ht+1v = ft(h
t
v, {(htw, evw) : w ∈ N(v)}) (2.8)
The readout phase compute an output vector using the final hidden states:
1Picture modified from [5]
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s = R({hTv |v ∈ G}) (2.9)
evw is the edge between v and w. Since we do not have edge attributes, this can be
omitted. N(v) denotes the neighbors of v in G. Usually 1-neighbor is used for N(v), but
one can define multi-hop neighbors. ft is the updating rule at time t, which can be different
across time. R is the readout function. ft and R need to be learned from data. The initial
hidden state is set to be the input feature on v. (i.e. h0v = xv).
It is worth pointing out that instead of iterating over all nodes in the graph, sometimes all
the hidden states at one time step are written as a matrix H t such that each row represents
the hidden state of one node. This formulation results in easy implementation with sparse
matrix multiplication in some cases.
Figure 2.1: neighborhood aggregation in graph neural network
2.3.2 Graph convolutional network







Here Ã = A+ IN is the adjacency matrix with self connections. IN is the identity matrix.
D̃ is the diagonal matrix such that D̃ii =
∑
j Ãij. W
(l) is the trainable weight matrix. σ(·)
is the nonlinear activation function such as ReLU. In the original paper the final aggregation
for readout is unnecessary because the method is tested with node classification. For our
purpose, we may use sum, mean or a fully connected layer on concatenation of hidden states
for the readout function R.
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One problem with this method is that it treats the node v and its neighbors equally. It is
more desirable that the centroid can be distinguished from the neighbors.
2.3.3 GraphSAGE
GraphSAGE [5] adopts the following forward propagation rule:








σ(·) is the non-linear activation function. W t is the weight matrix. (ht−1v , htN(v)) is the
concatenation of the two vectors. AGGt is the aggregation function. The authors provide
three options for the aggregation function, including mean aggregator, LSTM aggregator
and (max) pooling aggregator.
GraphSAGE also uses sampling to reduce the computational complexity. Instead of enu-
merating all the neighbors of a node, it randomly sample a fixed number of neighbors to
form N(v) at each iteration.
2.3.4 Gated graph neural network
The gated graph neural network (GG-NN) [8] works for graphs with different types of












where Aevw is a learned matrix that is shared across edges of the same type, and GRU
is the Gated Recurrent Unit. Parameters in GRU are shared across time steps and across
nodes. Horizontally (one time step over the whole graph), GG-NN performs convolution over
the graph. Vertically (one node over all time steps), GG-NN is a recurrent neural network
receiving inputs from neighbors over the time.





σ(i(hTv , xv)) tanh(j(hTv , xv))
)
(2.16)
where σ is the logistic sigmoid function,  is coordinate-wise multiplication, i(·), j(·) are
neural networks. The σ(i(hTv , xv)) part serves as an attention mechanism to decide which
node more relevant to the graph level task.
2.3.5 Graph attention network
Graph attention network (GAT) [9] introduces attention mechanism to decide the impor-
tance level among all the neighbors. Compared with the graph convolutional network in
section 2.3.2 which uses the normalized adjacency matrix to determine weights of neigh-
boring nodes, GAT directly computes the weight using self attention on the hidden states.















Here 〈, 〉 denotes inner product. || denotes concatenation of vectors. at and W t are
parameters for step t. The next hidden state is then computed using the attention coefficient






To stabilize self attention learning, the authors also propose to use multiple attention
channels. That is to compute K different ht+1v with independent parameters and concatenate
them together.
Similar to GG-NN in section 2.3.4, GAT controls the rate of update in neighborhood
aggregation. The difference is that GG-NN applies the same update rate for all the neighbors,
while GAT computes update rate for individual neighboring node by self attention.
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2.3.6 Hierarchical differentiable pooling
Most graph neural networks, such as those mentioned above, are mostly designed for
node level classification/embedding. Although these methods can be used for graph-level
prediction, they generally take an naive approach in the readout phase, such as mean or
average of node vectors. [10] introduces a hierarchical graph network that is specific for
graph level prediction. The intuition is that we can shrink the graph step by step and finally
the original graph is concentrated onto one node, which represents the whole graph. See
figure 2.2 for an illustration. 2
Figure 2.2: Hierarchically contract the graph to a single node
To contract the graph G into a smaller one G′, they model G and G′ together as a match-
ing graph and learn the node embeddings and adjacency matrix of G′ from G. Two separate
graph neural networks are run on G to obtain an embedding matrix and an assignment
matrix. Embedding matrix contains the node embeddings of vertices in G, while the assign-
ment matrix measures the edge weight between vertices in G and vertices in G′. These edges
”softly assign” vertices in G to vertices in G′. The adjacency matrix and node embeddings
of G′ are calculated based on this soft assignment. Such contraction may repeat for several
steps such that the final contracted graph contains only one node.
The method is highly flexible in the way that the graph neural network used to compute
the embedding matrix and assignment matrix can be any one mentioned before in this
section. More importantly, the graph level representation is obtained through a hierarchy of
graphs rather than a naive sum over nodes. However, this methods is computationally more
expensive since it uses two graph neural networks at each contraction step and typically 3-5
steps are needed for large graphs.
2.3.7 Challenges for GNN-based survival prediction
Although graph neural network is a promising approach to overcome the weakness of ex-
isting methods under the Cox model, there remain two challenges. First, there are around
2Picture from [10]
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20,000 human genes which constitute a large interaction graph. With the high computa-
tional complexity of graph neural network, evaluating the partial log-likelihood can be very
expensive as it requires running over the whole batch. Secondly, data for cancer patients
cannot cover all the genes as covered in a PPI network. We either need to filling the missing
information on part of the genes or prune the graph to fit the survival data. Effectiveness
for both approaches heavily rely on expert knowledge about the relative importance of each
gene. It is important to develop a learning algorithm that is both computationally and
statistically efficient for cancer progonostic prediction.
2.4 MESSAGE PASSING NEURAL NETWORK
2.4.1 Model architecture
As described in the previous section, most GNN architectures fall into the general frame-
work of message passing neural network. Hence, we propose our model with a message
passing phase followed by a readout phase.
Message passing phase
Let hk(u) be the hidden representation of node u at layer k. We use unweighted graph





hk+1(u) = ν([ak(u), hk(u)]) (2.21)
Here [·, ·] denotes concatenation of two vectors. µ, ν are two-layer ReLU networks (linear,
ReLU, linear, ReLU), µ : Rdk 7→ Rdk , ν : R2dk 7→ Rdk+1 . Both of them have hidden dimension
4. A batch norm layer with dk+1 channels is added before the final ReLU of ν.
Readout phase






Here f and g are two-layer ReLU networks like µ and ν. Here θ serves as the hazard ratio
in the cox regression. We minimize the partial log likelihood to train the model.
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Details
We set h0(u) = x(u) to be the input feature, which in our case is the RNA expression
value and standardized RNA expression value. We use two GCN layers as described in the
message passing phase. The hidden dimension dk = 32 for all layers. Hidden dimensions of




k respectively. Output dimension of g is d
1/2
k . The final output θ is
treated as the log relative hazard (the same θ as in section 1.2.1).
2.4.2 Loss function
The original partial log likelihood described in section 1.2.1 requires knowing the θ’s from
all patients, which means we need to train the model in full batch. Considering the scale
of the interaction graph (∼ 20,000) and the number of patients (∼ 1,000), the memory cost
would be infeasible. Hence we propose two memory efficient adaptation of the partial log
likelihood loss.
Minibatch partial log likelihood. We compute the partial log likelihood over B, a











This is reduced to the original partial log likelihood formula if B is set to be the whole
population.
Pairwise contrastive loss. Since the survival regression is essentially a partial ranking
problem, we can use the pairwise ranking loss. In each iteration, we take two individuals i
and j that are comparable in the cox model, say i lives longer than j. Then
Li,j(β) = max{0, θi − θj + δ} (2.24)
Here δ is the constant offset for hinge loss.
The proposed loss functions can be computed over a small minibatch and thus reduce the
memory cost. Empirically we find they do not make big difference in terms of accuracy, so
we only report the result with minibatch partial likelihood.
2.5 SPECTRAL GRAPH NEURAL NETWORK
Unlike the recent message passing architectures that aggregates local information for pre-
diction, spectral graph neural networks utilize spectral transformation that can be compu-
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tationally more efficient for cases where the graph topology is fixed for all inputs. We adapt
the architecture from [11] which proposed a fast localized spectral filter. This method has
been shown effective for breast cancer type classification [12].
Let G = (V,E) be the interaction graph with node set V and edge set E. Let xp ∈ Rn be
the graph signal (or gene expression) of patient p over the n nodes (or genes). L = D−A is
the graph Laplacian, where A is the weighted adjacency matrix and D is the degree matrix.
The graph convolution of signal x is defined as follows. Let L = UΛU> be an eigen
decomposition of L, and λ1, . . . , λn be the eigen values. The graph Fourier transform is
defined as x̂ = U>x and the inverse graph Fourier transform is defined as x = Ux̂. Then the
graph convolution operator ∗G is defined as
x ∗G y = U((U>x) (U>y)) (2.25)
= U((U>y) (U>x)) (2.26)
= Uy(Λ)(U>x) (2.27)
where  is the element-wise product, and y(Λ) = diag[ŷ(λ1), . . . , ŷ(λn)].
The Chebyshev polynomial Tk(x) is recursively defined as
Tk(x) = 2xTk−1(x)− Tk−2(x), (2.28)
with T0 = 1, T1 = x. The final graph convolution filter can be approximated as




where L̃ = 2L/λmax − In. The final result is obtained by an average pooling layer.
Since the spectral graph convolution method requires less memory, it is affordable to run
a full batch training. Thus we keep to the original partial log likelihood as our loss function.
2.6 EXPERIMENT
2.6.1 Data
The RNA expression data of breast cancer patients are downloaded from The Cancer
Genome Atlas Program (TCGA-BRCA). We use STRING protein-protein interaction net-
work [13] as the gene interaction network. Genes with missing values in expression data are
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removed and gene entrez ID from expression data are further mapped to STRING protein
ID. Table 1.1 shows the number of overlap genes from above data. Finally, we get 12032
genes on the interaction network with expression data
TCGA TCGA(no NaN) map STRING ppi
TCGA 18321 16821 16742
TCGA(no NaN) 12659 12048 12032
map 18593 18543
STRING ppi 19354
Table 2.1: Number of overlap genes
2.6.2 Result
We report the 5-fold cross validation result of C-Index on test set. For each split, we use
15% of training data for validation purpose. Results are compared against two baselines:
the linear Cox-PH model and multi-layer perceptron Cox model (Cox-MLP)[3]. In the table
below, ”Message passing” stands for message passing graph neural network, and ”Spectral”
stands for the spectral convolution neural network. For both proposed methods, we do early
stopping according to the C-Index on validation set which is evaluated every 10 epochs. We






Table 2.2: Performance comparison
2.6.3 Discussion
The performance of message passing is worse than the two baselines. We suspect the reason
is that message passing neural networks requires rich topological information during training,
but in our experiment, the underlying interaction graph is an invariant across samples, which
significantly limited the power of such kind of models. In general, graph neural networks are
used in both transductive and inductive scenarios. The survival prediction problem should
be considered as inductive learning. However, typically inductive learning on graphs requires
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a number of graphs that differ in graph topology. In our case, the graph topology is fixed,
and only node attributes change across training samples. Interestingly, when the STRING
PPI graph is replaced with a random graph, we get almost the same result, which indicates
that graph structure is poorly utilized.
On the other hand, the spectral graph convolution network performs the best among
all the models. This confirms us that information from biological interaction network is
useful for prognostic prediction in breast cancer, as compared to Cox-MLP and Cox-PH
which do not receive such information during training and inference. The success of spectral
method over message passing methods also demonstrate the importance of the model being
topologically invariant to input graphs, which improves not only the performance, but also
the computational efficiency as the topological information can be pre-computed.
2.7 CONCLUSION
We present the statistical model for survival prediction and identify the underlying ma-
chine learning problem. Although message passing-based graph neural networks seems a
promising approach to overcome the weakness of the classical Cox model, the empirical re-
sult is not satisfactory. On the other hand, spectral-based graph neural network achieves
strong performance over baselines, demonstrating the power of biological network in cancer
prognostic prediction. It is promising to explore other graph neural network architectures
for better performance in the future. It is also interesting to develop an algorithm to identify
important pathways over the interaction network that are unique to a disease.
From the machine learning perspective, though various message passing style graph neural
networks have achieved great success in tasks on social networks, academic graphs and
molecular structures, they may fail in other scenarios, as shown in our experiment. Diversity
in graph topology is critical for effectively training graph neural networks. On the other hand,
spectral based graph learning which is less popular these days turns out to be more effective
and more efficient for problems with fixed topology. Apart from our prognostic prediction
problem with genetic interaction network, there are other graph learning problems with fixed
graph topology such as predicting weather change or population growth across regions. It
would be valuable to study the computational methods applied in these domains and adapt
to cancer genomic problems.
Although this study has only focused on prognostic prediction of the breast cancer, the
philosophy could potentially be extended to many other prediction problems with gene
expressions or mutations. Biological interaction networks can always provided additional
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information about correlations between genetic covariants. We also suspect that using a
problem-specific network, rather than the general purpose network as in our experiment,
would potentially benefit the performance. For example, an interaction network constructed
from brain cells may be a better fit for predicting neurodegenerative diseases.
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CHAPTER 3: GENETIC ASSOCIATION STUDY FOR PARKINSON’S
DISEASE
3.1 INTRODUCTION
The advent of next generation sequencing (NGS) has facilitated the discovery of genetic
mutations in human diseases. In contrast to traditional SNP-array approach, NGS is most
effective in detecting rare genetics variants or structural genome changes. These genetic mu-
tations are likely to be associated with nervous system disorders, in particular the Parkinson’s
disease. The decreasing cost of NGS has provided an abundant resources of data on genetic
variants on the scale of whole exome sequencing (WES) or even whole genome sequencing
(WGS). However, we are facing the challenge of detecting significance of these rare variants
from the large scale data. Traditional statistical methods fail in this case largely due to the
sparsity of signals of rare variants.
It is crucial to devise novel methods with sufficient statistical power to reveal the effect of
rare variants on neurogenic diseases. Towards this end, several rare variant association tests
have been proposed. See [14] for a comprehensive survey over these methods. However, these
methods generally aggregate variant by contiguous chunks of loci over the genome, or simply
by genes, which potentially limits its power as they only consider rather simple patterns of
variant combinations. In the meanwhile, with the extreme sparsity of the data, it is likely
that some effective variants are missing (not revealed in experiments) due to limited sample
size. Hence, it is important to recover them during the analysis.
In this project, we leverage information from biological gene networks to assist the analysis
of rare variants. We adopt a technique called network diffusion to propagate gene-level
signals over the interaction graph to get a more comprehensive picture of overall mutation
profile of individual patients. By introducing biological networks, we are allowed to extend
aggregation patterns from aggregation within genes to across genes. The gene network also
makes it possible to determine the effect of genetic mutations that are not experimentally
measured. Our assumption is that variant impact comes from not only single genes but also
network harbors. In this way, we are able to recover important harbors by locality over the
gene network.
It is worth mentioning that the clinical data are used for evaluation only. Our method
is based on unsupervised clustering which requires no labels. The feature obtained from
random walk over the interaction graph allows us to cluster the patient profiles into groups
and we empirically find that these groups are highly correlated to disease phenotypes.
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3.2 RELATED WORK
In complement to GenomeWide Association Study (GWAS) for common variants, gene
or region based tests for rare variant association study have been recently proposed, most
of which use the idea of aggregating single variants with weak signals into larger group of
better statistical significance. One important class of these tests are termed as burden tests.
They collapse information for various genetic variants into a single score and test it against
a given trait. The cohort allelic sums test (CAST) ([15]) assumes equal weight for variants
in the same group and variants all have deleterious effects. However, these assumptions
are too strong in real cases. The Sequence Kernel Association Test (SKAT) ([16]), uses
a variance-component approach to estimate both positive and negative effects. Moreover,
SKAT models SNP-SNP interactions by adaptively assigning weight to each variant. SKAT.
Although SKAT outperforms burden tests when a large fraction of the variants in a region
are noncausal or the effects of causal variants are in different directions, it is inferior in
simpler cases when most variants are causal with the same direction of effects. SKAT-O
([17]) combines these two approaches to optimize the performance.
On the other hand, network diffusion has been widely adopted in association studies. Net-
work based stratification (NBS) has successfully applied network diffusion to type tumors by
propagating somatic mutation information over tumor-specific interaction networks.([18],[19])
While neurogenic diseases typically exhibit more complex patterns than cancers, we expect
the power of network diffusion can help in our case.
3.3 PROBLEM DEFINITION
Let M ∈ Rn×p be the patient-by-gene profile. The value Mij encodes the SNP information
of gene j in patient i, which can be either a binary value, or a normalized count. In the binary
case, Mij = 1 if there is at least one variant in the gene region, and Mij = 0 otherwise. In case
of count, we normalize the number of SNPs over the gene region by background mutations.
We also introduce a gene interaction network G = (V,E), whose vertices are all human
genes and edges are interactions. We always treat G as a weighted graph. If the network is
originally unweighted, we assign 0/1 weights to edges. The interaction network is shared for
all patients.
We formulate the problem as an unsupervised clustering. Our goal is to cluster all the
patients by their mutation profiles. To evaluate the resulting clusters, we use information
from clinical diagnosis of progression of Parkinson’s disease. Specifically, we look at the
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UPDRS score (Unified Parkinson Disease Rating Scale). The UPDRS score is computed
by rating on various Parkinson-related symptoms. For each patient, UPDRS is measured
multiple times over the years to reflect the progression of disease. In our study, we discretize
the timeline by a bin size of 10 months and take the average of UPDRS scores in the same
bin. Consequently, for each cluster of patients we can draw a curve of average UPDRS versus
time, which serves as the phenotype. An effective clustering algorithm should separate apart
curves from different clusters. In case of binary clustering, the result should correspond to
a high risk group and a low risk group.
3.4 METHOD
In this section, we describe our network-based stratification method. As described in the
previous section, our input data is a patient-by-gene mutation profile M , and an interaction
network G = (V,E).
To outline, our method consists of three main steps. First, since the network G may
be constructed for general purpose and not for our problem specifically, we need to find a
proper subnetwork with some prior domain knowledge (Section 4.1). By doing this we also
reduce the computational burden. The next step is to run random walk with restart over
the subgraph to get smoothed patient profiles (Section 4.2). Finally, we do clustering over
the result from network diffusion (Section 4.3).
3.4.1 Network Filtering
We first filter the network G by a pre-determined gene set S, which comes from (1)
important genes related to Parkinson’s disease found by previous studies, and (2) genes
corresponding to non-zero columns of our data matrix M (i.e. at least one patient has
a mutation on this gene). Although the original network G is usually well connected, its
subgraph directly from S may be fragmented. There are three criterions for choosing the
subgraph Ĝ:
1. Ĝ should be connected, for the sake of random walk in the next step.
2. Ĝ should contain as many genes from S as possible.
3. Ĝ should contain as few genes outside S as possible.
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For these three purposes, we first partition the induced subgraph of G from S into con-
nected components. We take the largest component c1 as the base and grow c1 by adding
other components. If another component ci can be connected to c1 via a single vertex v, we
attach ci and v to the existing subgraph. Otherwise, distance between ci and c1 would be
larger than 1, and we simply drop ci. Details of network filtering is in Algorithm 1.
Algorithm 3.1: Network filtering
Input: Network G = (V,E), Node Set S
GS = G.subgraph(S);
c1, c2, . . . , ck = ConnectedComponent(G
S);
Let c1 be the largest connected component.;
N = c1 for i← 2 to k do
if there is v ∈ V such that c1 and ci are connected through v then
Add ci to N;




3.4.2 Random Walk with Restart
We perform random walk with restart over the subnetwork obtained from the previous
step. Let A be the adjacency matrix of the subnetwork. The transition probability matrix





Let F0 = M be the initial state, Ft be the state at time t, and α be the restart probability.
At each iteration, we update Ft according to the following:
Ft+1 = (1− α)FtB + αF0 (3.2)
We iteratively update the state until the convergence criterion ||Ft+1 − Ft||F ≤ ε is met.
Here || · ||F is Frobenius norm, and ε is set to 10−6.
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3.4.3 Clustering
The output F̄ from random walk is an n×q matrix, where q equals the number of vertices
in the subnetwork. We reduce the dimension using singular value decomposition (SVD).
Formally,




Ud, Sd denote the first d columns of U , S respectively. We use d = 50 and take M as the
truncated patient profile. We further compute a cosine distance matrix D of rows in Md.
Dij = 1− cos(Mi,,Mj,) (3.5)
KMeans++ clustering is applied to matrix D to generate the final clusters.
3.5 EXPERIMENT
We evaluate our method on datasets from Parkinson’s Progression Markers Initiative
(PPMI). We extract Single nucleotide variants (SNVs) from both whole exome sequencing
data and target gene sequencing data. In this project, we only focus on nonsynonymous
exonic variants, which result in amino acid change in corresponding proteins. There totally
402 patients diagnosed with Parkinson’s disease from WES dataset, and 430 from target gene
sequencing dataset. Variant information in VCF format is converted to one patient-by-gene
matrix with binary values. The STRING protein-protein interaction network [13] is used
for random walk propagation. We run our algorithm on the mutation matrix and plot the
UPDRS curves of resulting clusters.
On both datasets our method can clearly separate the two curves apart, indicating that
the population is stratified into two groups with different risks. As expected, the whole
exome sequencing data gives a more comprehensive picture than the target gene sequencing
data that only covers a few hundred of genes. This also demonstrates the importance of
studying Parkinson’s disease on a whole-genome level to discover a larger set of relevant
genes.
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Figure 3.1: Target gene sequencing (binary)
Figure 3.2: Whole exome sequencing (binary)
3.5.1 Counting-based Variant Matrix
Instead of using binary indicators, we also tried normalized counting matrix as the input to
network diffusion. For each patient and each gene, we divide the number of nonsynonymous
exonic variants by the number of background variants on the same gene. Background types
include intronic, regulatory, and synonymous exonic variants, which we believe has less
impact on the disease. Below we present the results.
As one can see, using normalized count does not improve the result. We suspect this is
due to the type of variants in use. It is likely that even a single nonsynonymous variant
can result in malfunction of the whole protein, and thus the number of variants is not super
important.
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Figure 3.3: Target gene sequencing (count)
Figure 3.4: Whole exome sequencing (count)
3.5.2 Rare Variant Filtering
We also considered using rare variants only in whole exome sequencing dataset. For this
purpose, we filtered all nonsynonymous variants by Non-Finish European minor MAF in
ExAC ([20]) and CADD score ([21]). Specifically, we retain variants with NFE MAF < 0.02,
and CADD score > 10. The results are shown below (with binary mutations).
The result shows that common variants may still play an important role in Parkinson’s
disease, as the performance significantly decreases without them. It would be interesting to
study common variants and rare variants separately and then combine the results, which
will be done in further experiments.
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Figure 3.5: Rare variants only in whole exome sequencing
3.5.3 Splicing and regulatory effects
In addition to exonic mutations, we turn to variants with splicing and regulatory effects.
The whole genome study (WES) dataset is downloaded from PPMI website. Variants are
annotated by the Ensembl Variant Effect Predictor (Ensembl VEP) [22] and ANNOVAR
[23] for downstream effects. We collected variants with splicing effects and variants with
regulatory effects respectively. Results are shown in Figure 2.6 and Figure 2.7.
Figure 3.6: Variants with splicing effects
In contrast to the exonic variants, the splicing and regulatory variants show little discrim-
inative power for disease phenotypes. Although it is believed that regulatory variants play
an important role in neurodegenerative diseases, we may need to devise new algorithms to
explore their effects.
25
Figure 3.7: Variants with regulatory effects
3.6 CONCLUSION
We proposed a network-based stratification method to study rare variant association in
Parkinson’s disease. Compared to the classical single variant tests, our method considers a
large number of variants in a joint manner to predict their biological effects. Our method
also has an advantage over the class of burden tests in that we leverage domain knowledge
about genetic interactions by incorporating an interaction network. On one hand, the burden
tests simply condense variants over a particular gene into one number without considering
their interactions. On the other hand, statistically it is almost impossible to learn so many
second-order parameters of gene-gene correlations from limited patient profiles. The prior
knowledge from the summarized interaction network illuminates the relation between genes
and is able to guide the model to capture the joint effects of neighboring genes by signal
propagation, which overcomes data sparsity. Experiments on PPMI data show our method
overcomes the weakness of existing and is able to achieve a strong correlation with clinical
diagnosis.
It is worth mentioning that pre-filtration of genetic variants is critical for genetic asso-
ciation study. Should we study exonic variants, rare variants or regulatory variants? How
to combine the different results together. This is an interesting problem for future study.
For now we have simply condensed different kinds of variants of our concern together, but
ideally they should be treated differently. Constructing a large heterogeneous network to
incorporate all the type information would be a promising way, but may incur high compu-
tational cost due to large number of variants. Efficient training and inference algorithms are
required for handling variants of different types.
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We also hope to extend the NBS framework to supervised settings and perform pathway
detection to discover important genes for Parkinson’s disease that are previously unknown.
There have been works on plant genome-wide association studies using multiple linear re-
gressions. See [24] and [25]. Nevertheless, human genomics is more complicated than plants.
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